305 related articles for article (PubMed ID: 6609984)
21. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
Whisler RL; Newhouse YG; Lachman LB
J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
[TBL] [Abstract][Full Text] [Related]
22. Invariant chain associates with HLA class II antigens via its extracytoplasmic region.
Marks MS; Cresswell P
J Immunol; 1986 Apr; 136(7):2519-25. PubMed ID: 3512715
[TBL] [Abstract][Full Text] [Related]
23. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
24. Cell-free synthesis and processing of the heavy and light chains of HLA-DR antigens.
Korman AJ; Ploegh HL; Kaufman JF; Owen MJ; Strominger JL
J Exp Med; 1980 Aug; 152(2 Pt 2):65s-82s. PubMed ID: 6967942
[TBL] [Abstract][Full Text] [Related]
25. Characterization of HLA-DR antigens on leukaemic cells.
Newman RA; Greaves MF
Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
[TBL] [Abstract][Full Text] [Related]
26. [HLA-DR antigens: cellular expression and molecular structure].
Charron DJ
Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
[TBL] [Abstract][Full Text] [Related]
27. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
28. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
[TBL] [Abstract][Full Text] [Related]
29. A mannose 6-phosphate-containing N-linked glycopeptide derived from lysosomal acid lipase is bound to MHC class II in B lymphoblastoid cell lines.
Dustin ML; McCourt DW; Kornfeld S
J Immunol; 1996 Mar; 156(5):1841-7. PubMed ID: 8596035
[TBL] [Abstract][Full Text] [Related]
30. Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines.
Hemler ME; Strominger JL
J Immunol; 1982 Aug; 129(2):623-8. PubMed ID: 6177771
[TBL] [Abstract][Full Text] [Related]
31. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
Gomi K; Akinaga S; Oka T; Morimoto M
Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
[TBL] [Abstract][Full Text] [Related]
32. Biochemical variation of human Ia like antigens detected with monoclonal antibodies.
Cohen BB; Deane DL; Van Heyningen V; Guy K; Hutchins D; Moxley M; Steel CM
Clin Exp Immunol; 1983 Jul; 53(1):41-50. PubMed ID: 6191895
[TBL] [Abstract][Full Text] [Related]
33. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
34. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
[TBL] [Abstract][Full Text] [Related]
35. Invariant chain influences post-translational processing of HLA-DR molecules.
Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
[TBL] [Abstract][Full Text] [Related]
36. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
[TBL] [Abstract][Full Text] [Related]
37. Structure, biosynthesis, and polymorphism of chicken MHC class II (B-L) antigens and associated molecules.
Guillemot F; Turmel P; Charron D; Le Douarin N; Auffray C
J Immunol; 1986 Aug; 137(4):1251-7. PubMed ID: 2942601
[TBL] [Abstract][Full Text] [Related]
38. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
39. Biochemical comparison of HLA-DR molecules derived from autologous human T and B lymphoblasts.
Altevogt P; Fohlman J; Kurnick JT; Peterson P; Wigzell H
Eur J Immunol; 1980 Dec; 10(12):908-14. PubMed ID: 6258924
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
